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Prion protein fragments spanning helix 1 and both strands of
βb sheet (residues 125–170) show evidence for predominantly
helical propensity by CD and NMR
Gary J Sharman1, Nigel Kenward2, Huw E Williams1, Michael Landon2,
R John Mayer2 and Mark S Searle1
Background: Transmissible spongiform encephalopathies are a group of
neurodegenerative disorders of man and animals that are believed to be caused
by an α-helical to β-sheet conformational change in the prion protein, PrP.
Recently determined NMR structures of recombinant PrP (residues 121–231
and 90–231) have identified a short two-stranded anti-parallel β sheet in the
normal cellular form of the protein (PrPC). This β sheet has been suggested to
be involved in seeding the conformational transition to the disease-associated
form (PrPSc) via a partially unfolded intermediate state.
Results: We describe CD and NMR studies of three peptides (125–170,
142–170 and 156–170) that span the β-sheet and helix 1 region of PrP,
forming a large part of the putative PrPSc–PrPC binding site that has been
proposed to be important for self-seeding replication of PrPSc. The data
suggest that all three peptides in water have predominantly helical propensities,
which are enhanced in aqueous methanol (as judged by deviations from
random-coil Hα chemical shifts and 3JHα–NH values). Although the helical
propensity is most marked in the region corresponding to helix 1 (144–154), it
is also apparent for residues spanning the two β-strand sequences.
Conclusions: We have attempted to model the conformational properties of a
partially unfolded state of PrP using peptide fragments spanning the region
125–170. We find no evidence in the sequence for any intrinsic conformational
preference for the formation of extended β-like structure that might be involved
in promoting the PrPC–PrPSc conformational transition.
Introduction
The transmissible spongiform encephalopathies (TSEs)
are a group of neurodegenerative disorders found in many
mammals, including man [1]. The human diseases include
Creutzfeldt–Jakob disease (CJD), Gerstmann–Straüssler–
Sheinker syndrome (GSS), kuru, fatal familial insomnia
(FFI) and the variant of CJD (vCJD), which has been diag-
nosed recently in a small number of cases in the UK [2].
The most widely studied of the TSEs is scrapie in sheep
and goats, but there are also TSEs of mink and mule deer
as well as the by now notorious bovine spongiform
encephalopathy (BSE), which affects cattle, particularly in
the UK. For a review see [3].
Despite many years of research by numerous groups, there
is no evidence to suggest that the TSEs have microbiologi-
cal origin; indeed, no disease-specific nucleic acid of any
description has been identified to date. The molecular basis
of the disease appears to be a conformational polymorphism
involving the folding of the membrane-associated sialogly-
coprotein PrP. Cellular PrP is present in healthy individuals
(referred to as PrPC), but in diseased cases PrPC undergoes
a post-translational modification and adopts the distinct
PrPSc structure (Sc from scrapie). PrPSc has a protease-
resistant core and contains substantial amounts of β sheet,
whereas PrPC is largely α-helical and is sensitive to pro-
tease digestion [4]. It has been proposed that the TSEs
are caused by changes to this protein alone and that PrP is
the major, if not sole, component of the infectious agent
[5]. The name prion (for proteinaceous infectious particle)
has therefore become synonymous with the infectious
agent of the TSEs.
As well as being infectious, some of the TSEs are also
inherited disorders. There are families in which a point
mutation in the PrP gene leads to the development of the
spongiform encephalopathy [6–8]. These mutations seem
to cluster in regions of the PrP gene and may be associated
with an effect on the folding of the protein [9]. It also
appears that the exact amino acid present at particular
sites of the PrP protein (sites at which polymorphisms have
been found) can alter an individuals susceptibility to these
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diseases. All the patients who have contracted vCJD have
been homozygous for methionine at residue 129; people
with valine at this position have, as yet, not appeared with
the disease and transgenic mice that have this human PrP
gene have altered susceptibility to BSE transmission [10].
Because of the effects of protein sequence and polymor-
phisms on the susceptibility to disease, it has been pro-
posed that the prion acts as the disease agent by causing
PrPC to refold into PrPSc. The PrPSc is then able to self
propagate with neuropathogenic consequences [11]. If this
is the case, the three-dimensional structure of PrPC and
PrPSc must be elucidated to understand the involvement
of structural changes within the protein molecule. Using
computer modelling, Gasset et al. [12] proposed that PrPC
was a four-helix protein with helices located at residues
109–122, 129–140, 178–191 and 202–217. On becoming
PrPSc it was proposed that the structure adopted a two-
helix conformation and more β-sheet-like structure [13].
Gasset et al. [12] also examined the structures of synthetic
peptides that corresponded to the predicted helical regions.
They showed that in isolation, only residues correspond-
ing to the putative helix 2 (residues 129–141) adopted any
α helical conformation; the other proposed helices tended
to form β-sheet structures.
Recent NMR structures of recombinant mouse PrP(121–
231) [14] and hamster PrP(90–231) [15] have shown that
the tertiary structure of recombinant PrPC contains three
helices located at residues 144–154, 179–193 and 200–219.
β Strands are located at positions 128–131 (β1) and 161–
164 (β2) and in the tertiary structure of PrPC these form
an antiparallel β sheet. Riek et al. [14] suggested that the
β sheet region may be central to the conversion of PrPC
to PrPSc, together with residues in the region of helix 1
(Figure 1b), by forming part of the PrPSc–PrPC binding
site for the self-seeding replication of PrPSc (see below). A
recent paper reporting the discovery of an antibody that
binds PrPSc, but not PrPC, may indicate that the folded
structure of PrPC is somewhat different to the structure of
PrPSc [16]. The data show that the epitope for the anti-
PrPSc antibody constitutes a region of PrPSc that forms a
discontinuous region of the structures of PrPC so far deter-
mined. These conclusions seem to suggest that the tertiary
structure of PrPSc is substantially different to the structure
of recombinant PrP and the structures of the synthetic
peptides so far published.
Prion-propagation models
Two models, the nucleation-polymerisation model and
the catalytic or template-assistance model, have recently
been proposed to account for PrPSc propagation [17]. The
underlying feature of both of these models for prion
disease is that the prion polypeptide chain codes for two
(or more) conformational forms that are dependent on
either its environment or its complexation state. In the
nucleation-polymerisation model, the PrPSc multimer
seeds the polymerisation process in which PrPC mono-
mers are added to the growing polymer chain. Fragmenta-
tion of these polymer chains generates new seeds to fuel
exponential growth in the concentration of the polymeric
form. Infectious PrPSc has been proposed to act as a nuc-
leation seed, and inherited mutations are thought likely
to increase the affinity of the abnormal PrPC conformation
for polymer seeding. In the template-assistance model, the
PrPSc conformer is proposed to bind in a monomeric or
dimeric form to one or a number of molecules of PrPC
or PrP*, a partially unfolded intermediate state of PrPC.
Thus, the templating effect of PrPSc is proposed to con-
vert PrPC/PrP* to new PrPSc. Such a mechanism suggests
that the partially unfolded state, PrP*, may be amenable
to study through peptide fragments that mimic these
partially unfolded states.
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Figure 1
Amino acid sequence and NMR structure of PrPC. (a) A schematic
showing the sequences of the three peptides used in this study
(156–170; 142–170 and 125–170) and their relationship to the
secondary structure of mouse PrPC (β1, β-strand 1; β2, β-strand 2;
and H1, helix 1). Residues shown under the main sequence (top)
indicate differences between the human and mouse sequences.
Residue 129 is a Val→Met polymorphism in humans, which may have
important implications for susceptibility to the variant of CJD, vCJD.
(b) A ribbon diagram of the NMR structure of recombinant mouse
PrPC from Riek et al. [14], drawn using the program MOLMOL [41].
Residues in the sequence 125–170 are highlighted in black.
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Evidence has accrued in support of the sequence PrP(90–
145) playing a key role in the α-to-β conversion of PrPC
during PrPSc formation. Peptide studies have shown that
PrP(109–122) is important in mediating the PrPC and PrPSc
interaction during the conformational conversion [4]. The
recent NMR structures of PrP(121–231) [14] and PrP(90–
231) [15] have provided further insight into this process by
identifying a short element of anti-parallel β sheet that has
been suggested to act as a possible nucleation site for PrPSc
propagation [14].
This raises interesting possibilities regarding the involve-
ment of the sheet region in this transition. It is possible that
the sheet forms because of the high β propensity of the
residues within the sequence, and/or through stabilising ter-
tiary interactions with other parts of the structure. To
provide some insight into these various possibilities, we
have synthesised and characterised by CD and NMR
spectroscopy, three peptides that span portions of the
mouse prion protein sequence corresponding to the β sheet
(Figure 1a). These include a short peptide (156–170), which
spans the second β strand (β2); a medium-length peptide
(142–170), which contains helix 1 as well as β2 (α1–β2); and
a longer peptide sequence (125–170), which spans both
β strands and includes the intervening helix and loop
(β1–α1–β2).
Results and discussion
Peptide conformational analysis by circular dichroism
CD spectra of all three peptides at similar concentrations
in water are shown in Figure 2a. The shortest peptide
(156–170; β2) has a deep negative ellipticity below 200 nm
together with one or more weaker negative bands bet-
ween 210 nm and 220 nm. The data are indicative of a
predominantly random-coil conformation in equilibrium
with some folded (possibly helical) conformation [18,19].
A slightly positive band around 230 nm is characteristic of
absorbance by tyrosine residues, which are particularly
abundant in this sequence [20]. The two longer peptides
(142–170, α1–β2; and 125–170, β1–α1–β2) show a similar
absorption band at 210–220 nm, but the negative elliptic-
ity below 200 nm is significantly weaker. Addition of
methanol increases the proportion of folded structure for
all three peptides. The envelope at 210–220 nm deepens
considerably as the concentration of methanol increases,
giving the characteristic CD spectrum of an α helix
[18,19]. The methanol titration data at a constant peptide
concentration of 50 µM are shown in Figure 2b for pep-
tide α1–β2 (142–170). The deepening negative ellipticity
at 210–220 nm is accompanied by an increasingly positive
absorption at 200–190 nm. Both of these features suggest
a substantial population of α-helical structure in equilib-
rium with random coil. The change in ellipticity at
222 nm (inset in Figure 2b) shows a broad sigmoidal
curve, which, together with the isodichroic point at 206 nm,
suggests a two-state transition between random-coil and
helical conformation that is highly populated at higher
methanol concentrations.
Conformational analysis by NMR
The CD data suggest that all three peptides have some
propensity to form secondary structure, even in water, and
the conformational preferences were further characterised
using NMR spectroscopy. DQF-COSY [21], TOCSY [22]
and NOESY [23,24] spectra allowed a full sequential
assignment of all three peptides to be made. The finger-
print (NH–Hα) region of the TOCSY spectrum of peptide
125–170, recorded in 90% H2O/10% D2O solution at
pH 3.0 and at 283K, is shown in Figure 3 with assignments
indicated. NOE intensities were measured from NOESY
datasets, and 3JHα–NH coupling constants were extracted
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Figure 2
CD spectra of prion peptides. (a) Far-UV CD spectra of peptides
125–170, 142–170 and 156–170 in water at 50 µM concentration,
298K and pH 3.0. The mean residue ellipticity (θ) is plotted against the
wavelength. (b) The CD spectra of peptide 142–170 at increasing
concentrations of methanol at a constant peptide concentration of
50 µM. The inset shows the change in θ at 222 nm plotted as a
function of methanol concentration.
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from high-resolution DQF-COSY and ‘clean’ TOCSY
spectra [25]. We have used the recently described ran-
dom-coil model as a reference state for the unfolded
peptide against which any structure or structural propen-
sity can be measured [26,27]. This model uses the distrib-
ution of peptide backbone φ and ψ angles found within
coil regions of protein structures in the protein database to
predict NMR parameters such as coupling constants and
short or medium range NOEs in the random-coil state.
Deviations of Hα chemical-shift values from those charac-
teristic of the random coil are used widely in identifying
secondary structure preferences [28,29]. Downfield Hα
shifts (δobserved – δrandom coil; ∆δHα positive) are characteris-
tic of β-sheet secondary structure, whereas upfield shifts
(∆δHα negative) have been used to identify residues in
β-turn regions or α-helical structure. The shortest peptide,
β2 (156–170), appears to show some limited helical
propensity, with Hα chemical shifts largely upfield of
those in the random coil, by up to 0.2 ppm in a number of
cases (Figure 4a). The conformational propensity of the φ
backbone torsion angle as measured using 3JHα–NH values
also seems to reflect a degree of helical preference; values
are generally lower than those derived using the random-
coil model (Figure 5a); in a number of cases 3JHα–NH
values are substantially smaller, by up to 1.5 Hz (± 0.5 Hz),
as is evident for Arg156, Val161 and Val166. The random-
coil 3JHα–NH value for valine is generally slightly higher
than the average, reflecting the conformational preference
of this residue for β space [30]. Forcing valine to adopt a
higher proportion of α-helical structure results in a larger
change in its 3JHα–NH value, which reflects this population
weighting, in agreement with the experimental data for
Val161 and Val166.
Short-range NOEs provide an additional structural handle.
In an α helix, sequential NHs are close in space, whereas
the Hα–NH distance between sequentially neighbouring
residues is larger. The reverse is true in β sheets, and thus
the ratio of these two NOEs provides a sensitive measure
316 Folding & Design Vol 3 No 5
Figure 3
The fingerprint (NH–Hα) region of the TOCSY spectrum of peptide
125–170 in 90% H2O/10% D2O, pH 3.0, 283K. Assignments are
indicated using the one-letter amino acid code. Peaks labelled a and b
correspond to NH–Hβ correlations for Ser132/Ser135 (overlapped)
and Ser170, respectively.
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Figure 4
Hα chemical shift deviations from random coil. (a) A plot of Hα
chemical shift deviations from random-coil values (∆δHα) for peptides
125–170, 142–170 and 156–170 in water at 283K. The
corresponding regions of secondary structure identified in the folded
recombinant mouse protein are shown (β1, 128–131; β2, 161–164;
and helix 1, 144–154). (b) A plot of Hα chemical shift deviations from
random-coil values (∆δHα) for peptide 125–170 in water, 50% (v/v)
aqueous methanol and 90% (v/v) aqueous methanol at 283K.
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of backbone angle populations [27]. Although the Hα–
NH(i, i + 1)/NH–NH(i, i + 1) NOE ratio could not be deter-
mined for all residues because of overlap, where it could
be measured, it was typically in the range 0.8–3; a value of
1.5 was predicted for the random coil using the database
backbone-angle model. A value of 58 is expected for an
idealised β sheet and 0.25 for an α helix. No medium
range i, i + 3 or i, i + 4 Hα–NH NOEs, normally associated
with a significantly populated helical conformation, were
observed, suggesting that there is no well-formed helix in
this peptide [31]. It therefore seems that although the
individual amino acids appear to be populating helical
regions of the Ramachandran space more than they would
in a random coil, there is no regular hydrogen bonding
pattern characteristic of stable secondary structure.
What is apparent is that residues 161–164, which form
strand β2 in the folded PrP structure, show no propensity
to adopt an extended β-like conformation in isolation.
Moreover, Val161, whose rather small 3JHα–NH value was
highlighted above and which forms the first residue of the
strand β2, has a distinctly helical backbone conformational
preference. In recent studies of the folding of a β-hairpin
peptide in water, we examined in isolation one eight-resi-
due β strand of the hairpin and showed (from J values and
NOE intensity ratios) that these residues populate β space
to a much greater extent than expected in the random coil,
even though this short peptide forms no secondary struc-
ture interactions in solution [32]. In this case the amino
acid sequence strongly predisposes the peptide to form
β-like structure. There are also several other examples of
unstructured peptides which, nevertheless, show higher
than average β propensities [33–35]. In contrast, this is
evidently not the case for the PrP peptide fragment corre-
sponding to strand β2 (156–170); although residues 161–
164 in the NMR structures of recombinant PrP form one
β strand of a short anti-parallel β sheet, in isolation the cor-
responding residues show some weak helical propensity.
Peptide α1–β2 (142–170), encompassing helix 1 of the
PrPC structure as well as β-strand β2, has Hα chemical-
shift deviations from random-coil values (∆δHα) that are
also predominantly negative (Figure 4a). Again, we see that
overall there is a propensity for the individual residues to
populate helical backbone angles to a greater extent than is
expected for a random-coil conformation. The part of the
sequence for which the largest ∆δHα values are observed
(up to –0.4 ppm) corresponds to helix 1 (144–154) in the
folded protein, suggesting that here the peptide sequence
alone is coded for forming helical structure. As was the case
for the shorter peptide, however, none of the medium-
range NOEs normally associated with a significant popula-
tion of helix were observed anywhere along the sequence,
including residues of the helix 1 sequence. Again, this sug-
gests that despite the propensity of the individual residues
to preferentially populate helical space, there is no well-
formed helical conformation. It also appears that residues
142–155 have little effect on residues 156–170. Hα chemi-
cal shifts (and indeed NH and sidechain shifts) are very
similar for residues 156–170 in both the short and medium
peptides (Figure 4a).
In the longest of the three peptides (β1–α1–β2; 125-170),
Hα shifts are again predominantly upfield of random-coil
values (Figure 4a). The helix 1 region again shows the
largest shift deviations, consistent with a greater helical
propensity in this region of the sequence. 3JHα–NH values
further support these conclusions (Figure 5b). In the 146–
152 portion of helix 1, all residues have 3JHα–NH values
1–2 Hz smaller than in the random-coil model. Again
no clearly resolved medium-range NOEs between resi-
dues with an i, i + 3 or i, i + 4 relationship were observed
anywhere in the sequence, including the helix 1 region,
suggesting that despite the general helical preferences
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Figure 5
Coupling constant analysis for prion peptides in water. (a) Deviations
of 3JHα–NH coupling constants from random-coil values (∆JHα–NH) for
peptide 154–170 at 283K. (b) ∆JHα–NH data for peptide 125–170 at
283K. Asterisks indicate the position of proline and glycine residues in
(a) and/or residues for which coupling constants were not resolved in
(b) as a result of overlap. Residues in strands β1, β2 and helix 1 of the
folded structure are indicated.
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exhibited by ∆δHα and 3JHα–NH values, no well-formed
helical conformation is populated. Extensive overlap pre-
vented a meaningful analysis of the majority of short-
range NOE ratios, although the observation of strong
sequential NH–NH NOEs along the entire sequence is
consistent with a significant population of nascent helical
conformation.
Conformational analysis by NMR in aqueous methanol
The CD studies described above (Figure 2b) showed that
addition of methanol appears to increase the amount of
structure present in all three peptides, with a deepening
of the bands between 205 nm and 225 nm and a concomi-
tant reduction in the band below 200 nm, which becomes
strongly positive at high methanol concentrations. NMR
studies of 125–170 in 50% and 90% aqueous methanol
appear to support this conclusion. Deviations of Hα shifts
from random coil are generally increased over those for the
same peptide in water, with the general trend towards
larger downfield shifts, particularly in the helix 1 region,
144–154 (Figure 4b). Similar conclusions are drawn from
an analysis of 3JHα–NH values, which generally show a
further decrease in the presence of the organic co-solvent;
residues within the helix 1 region show particularly pro-
nounced changes (Figure 6). Notably, strong i, i + 1 NH–
NH NOEs were observed all along the sequence, with the
strongest in the helix 1 region.
βb-Sheet propensity of PrP fragments spanning residues
125–170
The longest peptide fragment studied, encompassing
β strands 1 and 2 and helix 1 of the prion protein (Figure 1),
shows no evidence for any tendency of any part of the
sequence to adopt an extended β-like conformation. No
long-range NOE interactions are detected that might
suggest formation of a compact folded structure in which
the two-stranded anti-parallel β sheet is populated to any
extent. Neither is there evidence for the gradual accretion
of secondary structure as the peptide chain length increases.
Hα shifts for residues 142–170 are very similar in peptides
142–170 and 125–170 (Figure 4a), discounting a coopera-
tive interaction between the various parts of the sequence
studied, despite their mutually close proximity in the
folded recombinant protein (Figure 1b). Most noticeably,
the observation of such strong sequential NH–NH NOEs
within the sequences corresponding to β strands 1 and 2
suggests helical rather than β sheet propensity, as do the
generally negative ∆δHα values and many coupling con-
stants that are significantly smaller (by up to 2 Hz) than
those expected for a random coil or β sheet conformation.
The observation of high helicity in peptide fragments cor-
responding to β-strand regions of proteins is not new.
Kuroda et al. [36] have illustrated this for β-lactoglobulin
peptides, and helical conformations have been shown to
be induced in β-hairpin peptides by the effects of organic
co-solvents [37].
In this work, we have attempted to model the conforma-
tional properties of a partially unfolded state of PrP using
peptide fragments spanning the region 125–170. We find no
evidence in the sequence for any intrinsic conformational
preference for the formation of extended β-like structure
that might promote the PrPC–PrPSc conformational transi-
tion. Previous results have suggested that regions of the
structure in contact with the β sheet, including the preced-
ing sequence (90–122) and hydrophobic tertiary interac-
tions with helix 3, are important for the transition to the
disease form. Nguyen et al. [4] have shown that the addition
of small amounts of 109–122 to either 104–122 or 129–141
induces β-sheet conformations in the 104–122 and 129–141
peptides [4]. Surprisingly, the 104–122 sequence is not
autocatalytic for this transition, even though it encompasses
the 109–122 sequence. In the recently published folded
structure of recombinant PrP (90–231), it is proposed that
several residues in the region 104–122 form a hydrophobic
cluster, which interacts with β-strand 1 [15]. Other interac-
tions with other parts of the sequence must also be involved
because the β sheet is also present in the folded structure of
the truncated protein spanning residues 121–231 [14]. An
examination of the structure of PrPC reveals that β-strand 2
and the loop region 132–142 wrap around helix 3 (202–219)
forming many hydrophobic contacts (Figure 7), suggesting
that residues on helix 3 may be involved in stabilising the
β-sheet conformation in β-strand 2. The importance of resi-
dues in helix 3 to the PrPC–PrPSc transition has been dem-
onstrated recently by mutation studies and an examination
of the effects of sequence polymorphism in preventing
PrPSc formation [38]. It is evident from our results that
these tertiary contacts, rather than any intrinsic conforma-
tional preference, are likely to be pivotal in modulating the
318 Folding & Design Vol 3 No 5
Figure 6
A comparison of deviations of 3JHα–NH coupling constants from
random-coil values (∆JHα–NH) for peptide 125–170 at 283K in water
and 50% (v/v) aqueous methanol. A ∆JHα–NH value of zero indicates the
position of a proline or glycine residue or where a coupling constant
could not be measured as a result of poor resolution. Residues in
strands β1, β2 and helix 1 of the folded structure are indicated.
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β-sheet conformational preferences within these regions,
perhaps also within any partially unfolded intermediate
states of PrP.
Two recent NMR papers have examined the structure of
the full-length hamster PrP(29–231) [39] and mouse
PrP(23–231) [40] prion proteins, including the N-terminal
region. In both cases, this region is highly flexible and
largely random coil. The structured core regions in both
cases are very similar to those already reported for the trun-
cated proteins [14,15]. Despite the unstructured nature of
the N-terminal region, one of these studies [39] has sug-
gested that the 29–125 region of the flexible tail, through
some transient interaction, may be involved in stabilising
the conformation of the 187–193 helical region that is
thought to be important in PrPC–PrPSc recognition. The
flexible regions are clearly biologically important because
PrP(121–231) is inactive, but PrP(90–231) shows activity. It
is still not clear whether the N-terminal region participates
in the normal cellular function of PrP in the unfolded state,
but its involvement in the conversion of PrPC to PrPSc
seems to be a highly context-dependent phenomenon [39].
Recent studies have identified a monoclonal antibody that
recognises a prion (PrPSc)-specific epitope [16]. Notably,
the epitope constitutes a region of PrPSc not compatible
with any single continuous region of the structure of PrPC
so far determined. To account for this observation, it has
been suggested that PrPC could undergo a structural
rearrangement such that helix 1 and the two strands of the
β sheet in PrPC could be replaced by the four β strands of
a greek-key motif. Such a model could be used to bring all
three segments of the epitope into spatial proximity in one
contiguous region of the structure. The proposed confor-
mational transition involves all the residues studied here in
the fragments spanning the sequence 125–170. Although
such a structural rearrangement is quite plausible, our
results do not support any intrinsic sequence propensity for
forming β-sheet-like motifs of this type, even in structure-
inducing media such as aqueous methanol. Such a re-
arrangement would have to be driven by the formation of
an alternative folded structure in which the β-sheet motif
was substantially stabilised from within the structure or
through protein oligomerisation.
Materials and methods
Peptides were synthesised on an Applied Biosystems 431A peptide
synthesiser using standard FastMoc™ chemistry (Applied Biosystems,
Foster City, CA). Peptides were deprotected, freeze dried and resus-
pended in water. Purification was by reverse-phase HPLC using a C18
column and an acetonitrile gradient of 0–70% (v/v) in 0.1% (v/v) trifluo-
roacetic acid/water. Fractions containing the peptides were collected,
pooled, freeze dried and their purity and composition were assessed by
repeat HPLC and mass spectrometry.
All NMR experiments were performed on a Bruker DRX500 spectrome-
ter on peptide samples of ∼2 mM concentration in D2O or 90% H2O/
10% D2O solution, pH 3.0, and 50% CD3OD/50% D2O or 50%
CD3OD/50% H2O with the pH initially adjusted to 3.0 in aqueous solu-
tion. This low pH was used because of precipitation of the peptide at
higher values. Peptide 156–170 was soluble over a wider pH range,
allowing data to be collected at both pH 3.0 and 4.5. Spectra were vir-
tually identical under these different conditions. Phase-sensitive DQF-
COSY, TOCSY, NOESY and ROESY experiments were performed at
283K, collecting 2k points in f2 and 512 points in f1. Quadrature detec-
tion in f1 was achieved using TPPI, and solvent suppression was
achieved by presaturation. TOCSY experiments employed a spin lock-
ing field of 5 kHz, and ROESY experiments used 2 kHz. Mixing times of
100 ms and 200 ms were used in NOESY experiments. All chemical
shifts were internally referenced to the sodium salt of trimethylsilyl-
propionate (TSP). Data were processed on a Silicon Graphics Indy
workstation using XWINNMR software. Typically, a sine-squared win-
dow function shifted by π/4–π/2 was applied in both dimensions, with
zero filling in f1 to 1k points. For the measurement of coupling con-
stants, high-resolution DQF-COSY and TOCSY with 8k points in f2
were used. Data were strip-transformed with zero filling to 32k in f2,
using a Gaussian window function. Coupling constants were measured
by deconvolution of extracted rows. One-dimensional spectra were
acquired with 32k data points and processed with 1–2 Hz line broaden-
ing, or a Gaussian function for the measurement of resolved couplings.
CD spectra were acquired using an AVIV model 62DS spectrometer
(Aviv Associates), using a 2 mm path length cell. Stock peptide solu-
tions were prepared by the appropriate dilution of NMR samples to give
50 µM solutions at pH 3.0 for analysis by CD at 298K. Typically, 16
scans were acquired using a 4 nm bandwidth from 250 nm to 190 nm
with a step size of 1 nm. The resulting data were smoothed and baseline
corrected. Spectra were also acquired with a bandwidth of 1 nm; these
were identical except for a significantly poorer signal-to-noise ratio.
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Figure 7
Part of the NMR structure of mouse PrPC of Riek et al. [14] showing
residues 125–170 and their relationship to helix 3. A number of
residue sidechains involved in hydrophobic interactions with helix 3
are highlighted.
125
170
156
142
Val166
Thr218
Cys214
Tyr163
Gln217
Val161
Met213
Met134
Thr216
Pro137
Helix 3
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